Pronova’s revenue and profit drop in Q2

Sunday 15 August 2010

Pronova BioPharma ASA, the Norwegian producer of omega-3 derived prescription products, posted a 2.6% decline in revenue in the second 2010 quarter to NOK 443.6 million (€55.9 million) and a 59% drop in net profit to NOK 51.7 million.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

Norway